Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease
about
Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanismSimvastatin inhibits the activation of p21ras and prevents the loss of dopaminergic neurons in a mouse model of Parkinson's diseaseProtein aggregation in the brain: the molecular basis for Alzheimer's and Parkinson's diseasesVascular risk factors and dementia: how to move forward?Neuroprotective and Therapeutic Strategies against Parkinson's Disease: Recent PerspectivesHuman isoprenoid synthase enzymes as therapeutic targetsThe Janus face of the heme oxygenase/biliverdin reductase system in Alzheimer disease: it's time for reconciliationStatins, cognition, and dementia—systematic review and methodological commentaryStatins reduce the neurofibrillary tangle burden in a mouse model of tauopathyIron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseasesPrediction of drug-target interactions and drug repositioning via network-based inferenceCholesterol-modifying strategies for Alzheimer's disease.Simvastatin enhances hippocampal long-term potentiation in C57BL/6 mice.Integrated molecular landscape of Parkinson's diseaseHigher serum total cholesterol levels in late middle age are associated with glucose hypometabolism in brain regions affected by Alzheimer's disease and normal aging.Neuroinflammation resulting from covert brain invasion by common viruses - a potential role in local and global neurodegeneration.Statin use and Parkinson's disease in Denmark.Transcriptional activation of low-density lipoprotein receptor gene by DJ-1 and effect of DJ-1 on cholesterol homeostasisGinkgo biloba extract and long-term cognitive decline: a 20-year follow-up population-based study.Long-term high-dose atorvastatin decreases brain oxidative and nitrosative stress in a preclinical model of Alzheimer disease: a novel mechanism of action.Cardiovascular prevention of cognitive decline.Cholesterol in brain disease: sometimes determinant and frequently implicated.Molecular mechanisms underlying the effects of statins in the central nervous system.Statin use and cognitive function: population-based observational study with long-term follow-upPleiotropic effects of the HMG-CoA reductase inhibitorsHMGCR is a genetic modifier for risk, age of onset and MCI conversion to Alzheimer's disease in a three cohorts study.Effects of statins on incident dementia in patients with type 2 DM: a population-based retrospective cohort study in Taiwan.Prospects of statins in Parkinson disease3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors in the treatment of central nervous system diseases.Statins, plasma cholesterol, and risk of Parkinson's disease: a prospective studyCholesterol level and statin use in Alzheimer disease: II. Review of human trials and recommendations.Alzheimer's disease: pathological mechanisms and recent insights.Linking lipids to Alzheimer's disease: cholesterol and beyond.Vascular risk factors aggravate the progression of Parkinson's disease: a five-year follow-up study in Chinese patientsStatin Use and the Risk of Parkinson's Disease: An Updated Meta-AnalysisSterol lipid metabolism in down syndrome revisited: down syndrome is associated with a selective reduction in serum brassicasterol levelsProspective study of statin use and risk of Parkinson disease.Low-density lipoprotein receptor-related protein 1: a physiological Aβ homeostatic mechanism with multiple therapeutic opportunities.Differential associations of plasma lipids with incident dementia and dementia subtypes in the 3C Study: A longitudinal, population-based prospective cohort studyStatin adherence and the risk of Parkinson's disease: A population-based cohort study.
P2860
Q24603957-8D5ED4AE-3F92-4A14-B6B7-2F2B7A0B7C7FQ24629942-65C96965-E5E5-4CE1-B035-6D7D75602BACQ24650014-A8C1B90C-ADED-41E6-A8EB-BDE6D1AC550FQ24650263-A81F125D-4954-46F1-BD10-5A33AAB6F103Q26747508-0316E081-3780-4DCC-9976-B68CF548D65DQ26822639-262B095C-539E-4870-8A7A-DC5626E02C9EQ26823454-7CB2EAB4-C136-4F68-8190-83FACADC9560Q26852778-75073299-543A-4CFC-BE6A-A9C45F251630Q28235507-BDABC784-01FE-4AA9-9F17-7DF1E6DFD9CEQ28388335-05C7ECD2-2CD7-4B07-B638-2FABD0D5B2CFQ28483634-E04AC829-DFBB-47AA-AB1F-B5FD7CF8757AQ33347051-62EF8DD3-BA6D-43AB-A82E-71427385F51BQ33665597-B1CFAC7A-D272-4CA7-AF4C-1A04F55FF54AQ33767544-212B3DC2-C0EA-4213-B324-5E08079C9A46Q33925913-3AF5F1E6-3366-4DF1-9412-067A17D3CD8AQ33965321-41DD1FEC-D9C0-49F7-98BE-876854055F42Q34020626-EE7199E7-23CC-4D93-BB04-EF88B7BD146BQ34292835-7FDB2EC9-0E00-48A2-B9B6-9DC316F2CA06Q34551041-E8597B42-FA4D-4B89-B250-8FB066F44236Q34556705-F9D8BA74-5FF1-4A4D-9918-C2D42F2242C2Q34557674-D352EDCD-9A2A-43B2-BD41-DC0AC104251DQ34621446-4764460B-30F5-44F0-A880-37F1D7644F6DQ34685463-4082741D-2454-44C8-9D22-D340F7150C54Q34776124-ADEB93CC-72A3-4945-BF02-8778FCA93AB6Q34894749-B4CA3116-D168-4DBB-979F-0039E8EDCB65Q35054347-48BD749D-C310-4397-B9CC-59FAAC94A65EQ35092836-458F04AD-F8BF-4281-834B-F439869EA216Q35094028-264CE4F6-9DB4-4092-A731-C7E850392AD8Q35111806-AB57C8CD-AC39-4CAE-8F45-F56C4C92EA22Q35328089-E8243133-AB89-4F41-9D5E-CFD1427ABB82Q35642416-1FCF6663-64CC-422E-8D64-CC5D8DD4F536Q35687044-C25937B6-7819-42D3-9C9C-E3E392B79E73Q35875480-313113BA-747E-45EB-AA33-FA4B26431132Q35958725-33494B08-6DFE-438B-9579-C9FEDA8D4541Q35971467-D824C802-8FC3-4A5A-9CE0-756CA699BD69Q35977501-0E84B579-5BE8-4BC6-A39A-975CBAF78182Q36100697-D37FB99B-384E-4576-B4DB-1267737CA9F7Q36205039-95058181-4D46-41E3-BE93-12F5D9208AFDQ36325378-DEA569BF-C62F-4CDF-B444-569DB18CA4FFQ36339785-C10D867B-6819-4093-AAA1-58E55E85AD00
P2860
Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease
description
2007 nî lūn-bûn
@nan
2007 թուականին հրատարակուած գիտական յօդուած
@hyw
2007 թվականին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease
@ast
Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease
@en
Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease
@nl
type
label
Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease
@ast
Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease
@en
Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease
@nl
prefLabel
Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease
@ast
Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease
@en
Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease
@nl
P2093
P2860
P50
P3181
P356
P1433
P1476
Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease
@en
P2093
Austin Lee
Nien-Chen Li
Stanley W Wang
P2860
P2888
P3181
P356
10.1186/1741-7015-5-20
P407
P577
2007-01-01T00:00:00Z
P5875
P6179
1009397731